Sophia Genetics Sa (SOPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -77,487 | -61,270 | -78,495 | -87,585 | -73,507 |
| Depreciation Amortization | 9,529 | 8,596 | 8,336 | 5,571 | 3,609 |
| Accounts receivable | -6,603 | 5,892 | -6,500 | 1,332 | 1,806 |
| Accounts payable and accrued liabilities | 16,930 | -7,385 | 6,871 | -1,428 | 8,980 |
| Other Working Capital | 10,507 | -3,117 | 872 | -1,273 | 6,065 |
| Other Operating Activity | 11,231 | 12,769 | 20,341 | 13,290 | -4,892 |
| Operating Cash Flow | $-35,893 | $-44,515 | $-48,575 | $-70,093 | $-57,939 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 17,546 | 78,533 | 21,878 |
| PPE Investments | -574 | -244 | -1,494 | -4,097 | -2,683 |
| Purchase Of Investment | -1,885 | N/A | N/A | -26,179 | -72,141 |
| Purchase Sale Intangibles | -108 | -195 | -263 | -464 | -130 |
| Other Investing Activity | -6,211 | -4,511 | -7,732 | -6,284 | -3,988 |
| Investing Cash Flow | $-8,670 | $-4,755 | $8,320 | $41,973 | $-56,934 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 34,563 | 13,930 | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | N/A | -3,167 |
| Common Stock Issued | 1,439 | 405 | 226 | 748 | 216,190 |
| Other Financing Activity | -5,825 | -4,478 | -3,043 | -2,316 | 24,750 |
| Financing Cash Flow | $30,177 | $9,857 | $-2,817 | $-1,568 | $237,773 |
| Exchange Rate Effect | 4,449 | -3,612 | 5,018 | -1,969 | -4,563 |
| Beginning Cash Position | 80,226 | 123,251 | 161,305 | 192,962 | 74,625 |
| End Cash Position | 70,289 | 80,226 | 123,251 | 161,305 | 192,962 |
| Net Cash Flow | $-9,937 | $-43,025 | $-38,054 | $-31,657 | $118,337 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,893 | -44,515 | -48,575 | -70,093 | -57,939 |
| Capital Expenditure | -574 | -244 | -1,494 | -4,097 | -2,683 |
| Free Cash Flow | -36,467 | -44,759 | -50,069 | -74,190 | -60,622 |